As of 2024-12-14, the Intrinsic Value of Amphastar Pharmaceuticals Inc (AMPH) is
58.48 USD. This AMPH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 44.50 USD, the upside of Amphastar Pharmaceuticals Inc is
31.40%.
The range of the Intrinsic Value is 40.29 - 102.05 USD
58.48 USD
Intrinsic Value
AMPH Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
40.29 - 102.05 |
58.48 |
31.4% |
| DCF (Growth 10y) |
60.43 - 143.55 |
85.08 |
91.2% |
| DCF (EBITDA 5y) |
39.76 - 58.39 |
49.23 |
10.6% |
| DCF (EBITDA 10y) |
55.95 - 83.48 |
69.17 |
55.4% |
| Fair Value |
81.52 - 81.52 |
81.52 |
83.19% |
| P/E |
19.37 - 30.64 |
21.27 |
-52.2% |
| EV/EBITDA |
31.49 - 48.67 |
42.34 |
-4.9% |
| EPV |
14.25 - 23.27 |
18.76 |
-57.8% |
| DDM - Stable |
27.99 - 75.58 |
51.78 |
16.4% |
| DDM - Multi |
39.08 - 82.20 |
53.00 |
19.1% |
AMPH Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2,152.47 |
| Beta |
0.50 |
| Outstanding shares (mil) |
48.37 |
| Enterprise Value (mil) |
2,557.05 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.02% |
| Cost of Debt |
6.93% |
| WACC |
7.44% |